Summary
We performed a double-blind, placebo-controlled, crossover trial of sulfamethoxazole-trimethoprim (S-T) in 8 patients with Machado-Joseph disease (MJD), and measured the blood and cerebrospinal fluid levels of biopterins, biogenic amines or metabolites, and folate. The clinical results were as follows; mild improvements of hyperreflexia of knee jerks and of rigospasticity of the legs during S-T treatment period. In addition, S-T significantly reduced the times of 8 motor activities on the timed tests. The biochemical results showed that basal levels of all biopterins and homovanillic acid in the cerebrospinal fluid (CSF) were reduced to less than half the levels of those of controls with other neurological diseases. After S-T treatment, total and oxidized form of biopterins in the CSF increased significantly. Therefore, S-T may be effective to neurologic deficits through its mechanism of increasing the level of brain biopterins.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Blau N, Heizmann CW, Sperl W, Korenke GC, Hoffmann GF, Smooker PM, Cotton RGH (1992) Atypical (mild) forms of dihydropteridine reductase deficiency: neurochemical evaluation and mutation detection. Pediatr Res 32: 726–730
Bredt DS, Hwang PM, Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768–770
Burchall JJ (1973) Mechanism of action of trimethoprim-sulfamethoxazole II. J Infect Dis [Suppl] 128: 437–441
Coutinho P, Andrade C (1978) Autosomal dominant system degeneration in Portuguese families of the Azores islands. Neurology 28: 703–709
Dahl H-HM, Hutchinson W, McAdam W, Wake S, Morgan FJ, Cotton RGH (1987) Human dihydropteridine reductase: characterisation of a cDNA clone and its use in analysis of patients with dihydropteridine reductase deficiency. Nucleic Acids Res 15: 1921–1932
Desaiah D, Joshi P, Vig PJS, Subramony SH, Currier RD (1994) Cerebellar nitric oxide synthase activity in patients with spinocerebellar ataxia-1 [abstract]. Neurology [Suppl 2] 44: 369–370
Finch RG, Snyder IS (1990) Synthetic organic antimicrobials (sulfonamides, trimethoprim, nitrofurans, nalidixic acid, methenamine). In: Craig CR, Stitzel RE (eds) Modern pharmacology, 3rd ed. Little, Brown and Company, Boston, pp 642–653
Fink JK, Barton N., Cohen W, Lovenberg W, Burns RS, Hallet M (1988) Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology 38: 707–711
Fujishiro K, Hagihara M, Takahashi A, Nagatsu T (1990) Concentrations of neopterin and biopterin in the cerebrospinal fluid of patients with Parkinson's disease. Biochem Med Metab Biol 44: 97–100
Fukushima T, Nixon J (1980) Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 102: 176–188
Furukawa Y, Kondo T, Nishi K, Yokochi F, Narabayashi H (1991) Total biopterin levels in the ventricular CSF of patients with Parkinson's disease: a comparison between akineto-rigid and tremor types. J Neurol Sci 103: 232–237
Grossman A, Rosenberg RN, Warmoth L (1987) Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Neurology 37: 106–111
Kaufman S, Holtzman NA, Milstien S, Butler IJ, Krumholz A (1975) Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med 293: 785–790
Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, Kimura J, Narumiya S, Kakizuka A (1994) CAG expansions in a novel gene from Machado-Joseph disease at chromosome 14q32.1. Nature Genet 8: 221–228
Kay AD, Milstien S, Kaufman S, Creasey H, Haxby JV, Cutler NR, Rapoport SI (1986) Cerebrospinal fluid biopterin is decreased in Alzheimer's disease. Arch Neurol 43: 996–999
Komori H, Matsuishi T, Yamada S, Ichikawa K, Amamoto M, Yamashita F (1994) Elevated biopterin and homovanillic acid levels in cerebrospinal fluid from children with aseptic meningitis. J Child Neurol 9: 22–25
Koshimura K, Miwa S, Lee K, Fujiwara M, Watanabe Y (1990) Enhancement of dopamine elease in vivo from the rat striatum by dialytic perfusion of 6R-L-erythro-5,6,7,8- tetrahydrobiopterin. J Neurochem 54: 1391–1397
Lockyer J, Cook RG, Milstien S, Kaufman S, Woo SL, Ledley FD (1987) Structure and expression of human dihydropteridine reductase. Proc Natl Acad Sci USA 84: 3329–3333
Mataga N, Imamura K, Watanabe Y (1991) 6R-Tetrahydrobiopterin perfusion enhances dopamine, serotonin and glutamate outputs in dialysate from rat striatum and frontal cortex. Brain Res 551: 64–71
Mello KA, Abbott BP (1988) Effect of sulfamethoxazole and trimethoprim on neurologic dysfunctions in a patient with Joseph's disease. Arch Neurol 45: 210–213
Moncada S, Higgs A (1993) Mechanism of disease: the L-arginine-nitric oxide pathway. N Engl J Med 329: 2002–2012
Nagatsu T, Horikoshi T, Sawada M, Nagatsu I, Kondo T, Iizuka R, Narabayashi H (1986) Biosynthesis of tetrahydrobiopterin in parkinsonian human brain. In: Yahr MD, Bergmann KJ (eds) Advances in neurology, vol 45. Raven Press, New York, pp 223–226
Nakano KK, Dawson DM, Spence A (1972) Machado disease: a hereditary ataxia in Portuguese emigrants to Massachusette. Neurology 22: 49–55
Niederwieser A, Blau N, Wang M, Joller P, Atarés Cardesa-Garcia J (1984) GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenyl-alaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur J Pediatr 141: 208–214
Noro H, Minami R (1992) Effects of combination of sulfamethoxazole and trimethoprim on cerebellar ataxia and spasticity in a patient with Joseph's diesase type II. Neurol Ther 9: 279–283 (English abstract)
Nunokawa Y, Ishihara T, Kanai T, Noguchi T (1992) (6R)-5,6,7,8-tetrahydro-L-biopterin modulates nitric oxide-associated soluble guanylate cyclase activity in the rat cerebellum. Arch Biochem Biophys 298: 726–730
Ohue T, Koshimura K, Takagi Y, Watanabe Y, Miwa S, Masaki T (1993) Enhancement of acetylcholine release in the hippocampus by 6R-L-erythro-5,6,7,8-tetrahydrobiopterin is mediated by 5-hydroxytryptamine. Brain Res 607: 255–260
Ratnam S, Ratnam M, Cotton RGH, Jennings IG, Freisheim JH (1989) Anti-idiotypic antibodies elicited by pterin recognize active site epitopes in dihydrofolate reductases and dihydropteridine reductase. Arch Biochem Biophys 275: 344–353
Rosenberg RN (1991) Joseph disease: an autosomal dominant motor system degeneration. In: de Jong JN (ed) Handbook of clinical neurology, revised series. Hereditary neuropathies and spinocerebellar atrophies, vol 16(60). Elsevier, New York, pp 467–479
Rosenberg RN, Thomas L, Baskin F, Kirkpatrick J, Bay C, Nyhan WL (1979) Joseph disease: protein patterns in fibroblasts and brain. Neurology 29: 917–926
Sakai T, Ohta M, Ishino H (1983) Joseph disease in a non-Portuguese family. Neurology 33: 74–80
Sakai T (1989) Clinical characteristics of Joseph disease. A proposal of diagnostic criteria. Neurol Med (Tokyo) 30: 246–252 (in Japanese)
Sakai T, Oda K (1993) Abundant reinnervation in peripheral nerves in Joseph disease. Neurology 43: 428–430
Sangla S, Broucker TD, Cheron F, Cambier J, Dehen H (1990) Amélioration d'une maladie de Joseph par le sulfaméthoxazole-triméthoprim. Rev Neurol (Paris) 146: 213–214
Sawada M, Hirata Y, Arai H, Iizuka R, Nagatsu T (1987) Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer type. J Neurochem 48: 760–764
Shintaku H, Niederwieser A, Leimbacher W, Curtius HC (1988) Tetrahydrobiopterin deficiency: assay for 6-pyruvoyl-tetrahydropterin synthase activity in erythrocytes, and detection of patients and heterozygous carriers. Eur J Pediatr 147: 15–19
Spinella GM, Sheridan PH (1992) Research initiatives on Machado-Joesph disease: National Institute of Neurological Disorders and Stroke workshop summary. Neurology 42: 2048–2051
Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y, Shimazaki H, Soutome M, Endo K, Ohta S, Kagawa Y, Kanazawa I, Mizuno Y, Yoshida M, Yuasa T, Horikawa Y, Oyanagi K, Nagai H, Kondo T, Inuzuka T, Onodera O, Tsuji S (1993) The gene for Machado-Joseph disease maps to human chromosome 14q. Nature Genet 4: 300–304
Takiyama Y, Hanyu S, Niijima K, Mizuno Y, Yoshida M (1990) Effect of sulfamethoxazole and trimethoprim (BactaR) on Machado-Joseph disease: a doubleblind, placebo-controlled trial. Neurol Med (Tokyo) 32: 594–600 (English abstract)
Woods BT, Schaumburg HH (1972) Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia: an unique and partially treatable clinicopathological entity. J Neurol Sci 17: 149–166
Yokoo H, Kojima H, Yamada S, Tsutsumi T, Anno N, Anraku S, Nishi S, Inanaga K (1990) Simultaneous determination of dopamine, serotonin, 3,4-dihydroxy-phenyl-acetic acid, homovanillic acid, 3-methoxytyramine and 5-hydroxyindole-3-acetic acid by high performance liquid chromatography with electrochemical detection. Kurume Med J 32: 75–80
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sakai, T., Matsuishi, T., Yamada, S. et al. Sulfamethoxazole-trimethoprim double-blind, placebo-controlled, crossover trial in Machado-Joseph disease: sulfamethoxazole-trimethoprim increases cerebrospinal fluid level of biopterin. J. Neural Transmission 102, 159–172 (1995). https://doi.org/10.1007/BF01276511
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01276511